Ustekinumab - PDFSEARCH.IO - Document Search Engine

Ustekinumab
Results: 77

#	Item
21	2013 Business Highlights Johnson & Johnson delivered strong results in 2013 led by the outstanding performance in our Pharmaceutical business, the relaunch and strength of key brands in our U.S. over-the-counter (OTC) an Add to Reading List Source URL: 2013annualreport.jnj.com Language: English - Date: 2014-03-07 15:21:20 Centocor Health Monoclonal antibodies Johnson & Johnson Golimumab Ustekinumab Synthes Infliximab Biologic Pharmacology Medicine Immunosuppressants
22	Sharps Disposal Plan for Janssen Biotech, Inc. (Janssen) Janssen Biotech, Inc. is a Johnson & Johnson (J&J) company. J&J is committed to the health and wellbeing of families everywhere. Our commitment is evident in the v Add to Reading List Source URL: www.janssenbiotech.com Language: English - Date: 2014-01-16 10:51:28 Medical equipment Medical ethics Immunosuppressants Monoclonal antibodies Ustekinumab Golimumab Johnson & Johnson Medical waste Stericycle Medicine Centocor Pharmacology
23	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement Add to Reading List Source URL: www.janssen.com Language: English - Date: 2014-11-14 09:39:18 Piperazines Centocor Immunosuppressants Monoclonal antibodies Amines Tapentadol Ustekinumab Infliximab Levofloxacin Chemistry Pharmacology Medicine
24	1 Version Oct[removed]What can you do to manage your psoriasis? A decision aid for psoriasis patients Add to Reading List Source URL: www.healthyimage.ca Language: English - Date: 2012-10-29 12:12:39 Health Monoclonal antibodies Centocor Autoimmune diseases Ustekinumab Psoriatic arthritis Adalimumab Alefacept Light therapy Medicine Psoriasis Immunosuppressants
25	FDA Briefing Document Dermatologic and Ophthalmic Drugs Advisory Committee Meeting October 20, 2014 BACKGROUND PACKAGE FOR BLA[removed] Add to Reading List Source URL: www.fda.gov Language: English Health Clinical research Design of experiments Centocor Monoclonal antibodies Clinical trial Psoriasis Ustekinumab Tapentadol Pharmacology Medicine Immunosuppressants
26	Secukinumab (AIN457) ADVISORY COMMITTEE BRIEFING MATERIAL: AVAILABLE FOR PUBLIC RELEASE Prepared by Novartis Pharmaceuticals Corporation for the Add to Reading List Source URL: www.fda.gov Language: English Psoriasis Health Monoclonal antibodies Etanercept Placebo Ustekinumab Infliximab Medicine Immunosuppressants Pharmacology
27	Landon State Office Building 900 SW Jackson Street, Room 900-N Topeka, KS[removed]Phone: [removed]Fax: [removed] Add to Reading List Source URL: www.kdheks.gov Language: English - Date: 2012-03-29 08:05:49 Immunosuppressants Peptide hormones Bile acid sequestrants Hepatology Exenatide Anakinra Rivaroxaban Ustekinumab Liraglutide Medicine Anti-diabetic drugs Anatomy
28	Drug Utilization Review Board Add to Reading List Source URL: www.kdheks.gov Language: English - Date: 2012-08-24 08:50:59 Meetings Minutes Parliamentary procedure Attention deficit hyperactivity disorder Ustekinumab Food and Drug Administration Medicine Pharmaceutical sciences Pharmacology
29	Landon State Office Building 900 SW Jackson Street, Room 900-N Topeka, KS[removed]Phone: [removed]Fax: [removed] Add to Reading List Source URL: www.kdheks.gov Language: English - Date: 2013-12-24 13:09:16 Clinical pharmacology Food and Drug Administration Therapeutics United States Public Health Service Ustekinumab Telaprevir Pharmaceutical sciences Pharmacology Clinical research
30	Johnson Medal Awardees 1 YEAR 2012 Add to Reading List Source URL: www.jnj.com Language: English - Date: 2013-05-22 12:29:43 Organic chemistry Chemistry Ustekinumab Janssen Pharmaceutica Darunavir Paliperidone Golimumab Acuvue Nicorette Centocor Johnson & Johnson Medicine